Health Care & Life Sciences » Biotechnology | Cerenis Therapeutics Holding

Cerenis Therapeutics Holding S.A. | Key People and Executives

Richard C. Pasternak
Chairman
Jean-Louis Dasseux
President, Chief Executive Officer & Director
Karen Noël
Director
Olivier Martinez
Director
Barbara Yanni
Independent Director
Laura A. Coruzzi
Independent Director
Michael H. Davidson
Independent Director
Christian Chavy
Independent Director
Richard C. Pasternak
Chairman
Jean-Louis Dasseux
President, Chief Executive Officer & Director
Constance Keyserling
Senior VP-Clinical Development & Operation
Cyrille Tupin
Chief Financial Officer & Director-Administration
Renee Benghozi
Chief Medical Officer
Karen Noël
Director
Olivier Martinez
Director
Shawn Benoit
Management Controller
Emmanuel de Fougeroux
Director-Accounting
Barbara Yanni
Independent Director
Laura A. Coruzzi
Independent Director
Michael H. Davidson
Independent Director
Christian Chavy
Independent Director

About Cerenis Therapeutics Holding

View Profile
Address
33-43, av. Georges Pompidou- Bât. D2
Balma Midi-Pyrenees 31130
France
Employees -
Website http://www.cerenis.com
Updated 07/08/2019
Cerenis Therapeutics Holding SA is a biopharmaceutical company, which engages in development of high density lipoprotein therapies for the treatment of cardiovascular and metabolic diseases. Its therapies consist of CER 001 and 209. The company was founded by Jean-Louis Dasseux on March 24, 2005 and is headquartered in Labege, France.